Rafferty Asset Management, LLC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1389426 New York, NY

Position in ORIC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,463,131

+$13,807 QoQ

Shares Held

115,480

-34.8% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. ORIC ranks #83 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,572	$24,368,580
2	REGN	Regeneron Pharmaceuticals, Inc.	29,589	$22,861,644
3	INSM	INSMED Inc	116,069	$18,979,602
4	ALNY	Alnylam Pharmaceuticals, Inc.	50,553	$16,726,471
5	APLS	Apellis Pharmaceuticals, Inc.	180,471	$7,260,348
6	MRNA	Moderna, Inc.	114,194	$5,801,055
7	INCY	Incyte Corp	60,565	$5,700,377
8	MDGL	Madrigal Pharmaceuticals, Inc.	10,452	$5,471,308

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,463,131	115,480	-34.8%	Shares	Sole	2026-05-15
2025-12-31	$1,449,324	177,179	+107.0%	Shares	Sole	2026-02-13
2025-09-30	$1,027,104	85,592	+100.7%	Shares	Sole	2025-11-12
2025-06-30	$432,836	42,644	-44.9%	Shares	Sole	2025-08-14
2025-03-31	$432,025	77,424	+50.7%	Shares	Sole	2025-05-14
2024-12-31	$414,733	51,392	-20.4%	Shares	Sole	2025-02-14
2024-09-30	$661,996	64,585	-44.4%	Shares	Sole	2024-11-13
2024-06-30	$821,590	116,208	+4.6%	Shares	Sole	2024-08-13
2024-03-31	$1,528,257	111,146	+62.4%	Shares	Sole	2024-05-13
2021-12-31	$1,005,818	68,423	+118.5%	Shares	Sole	2022-02-10
2021-09-30	$654,713	31,311	-34.3%	Shares	Sole	2021-11-10
2021-06-30	$842,645	47,634	-29.3%	Shares	Sole	2021-08-10
2021-03-31	$1,650,418	67,364	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.